Medidata Named Leading Clinical Data and Analytics Platform Provider
New York - September 12, 2023 - Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, was named a Leader in Everest Group’s inaugural “Life Sciences Clinical Data and Analytics (D&A) Platform PEAK Matrix Assessment 2023.” The report evaluated the vision, capabilities, and market impact of 14 clinical D&A platform providers based on customer feedback, revenue, and capability demonstrations.
Everest identified Medidata as a leader due to its longstanding industry presence, the breadth of its analytics capabilities, and its wide partnership network. Medidata was individually recognized for combining its robust repository of clinical data with an end-to-end platform encompassing all aspects of the clinical trial process. The assessment spoke to the strengths of Medidata’s platform, including:
- A simple user interface (UI) with easy-to-access dashboards
- Real-time visibility to all data on the platform
- Wide range of use cases including anomaly detection, patient monitoring, integrated data views, site selection, and enrollment forecasting
The Medidata platform arms biopharmaceutical and medical device companies and clinical research organizations (CRO) with the extensive data management, integration, analytics, artificial, and business intelligence capabilities needed to bring safer and more effective treatments to market and to patients.
"We are humbled to be named a leader in Everest’s inaugural Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix Assessment,” said Tom Doyle, senior vice president and Chief Technology Officer, Medidata. “This recognition reinforces how Medidata’s versatile platform delivers best-in-class, comprehensive solutions to provide our clients with an accurate, integrated view of real-time, clinical data and bring new treatments more quickly to the patients that need them.”
Medidata's platform of clinical solutions enable seamless data acquisition, integration, and interrogation across many sources while prioritizing aggregation, standardization, and quality. Data collected with Medidata’s solutions or acquired externally is connected and surfaced in a single location without the need for manual re-entry, reconciliation, or uploads and ensures data interoperability, security, and compliance. With the industry's largest historical dataset and deep data science expertise, Medidata helps clients generate critical insights and evidence needed to improve decision-making across all aspects of the clinical trial process.